Navigation Links
Research Volunteer Registry from Verified Clinical Trials Adopted by ICON
Date:12/17/2012

Garden City, New York (PRWEB) December 17, 2012

Verified Clinical Trials today announced that ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, is using its research volunteer registry in its Clinical Pharmacology units in the US to ensure volunteer safety and clinical data quality.

The Verified Clinical Trials online registry, currently available in the US and Canada, prevents multiple trial enrollment and premature re-enrollment into another study by a research subject. The clinical research database volunteer registry safeguards data integrity and patient safety without delaying the screening process by ensuring that only qualified research subjects are enrolled in a study.

Dr. Mitchell D. Efros, CEO of Verified Clinical Trials, stated "ICON is one of the world's largest and most prominent leaders in the clinical trial business and their adoption of the Verified Clinical Trials registry significantly strengthens our network. By utilizing Verified Clinical Trials, ICON has further demonstrated its commitment to providing high quality clinical research data. Verified Clinical Trials continues to partner with many of the world's largest CROs and pharmaceutical companies in the world."

“Simultaneous study enrollment places the health of the volunteer at risk and may compromise the integrity of clinical data,” commented Mario Rocci, President, ICON Development Solutions. “The Verified Clinical Trials volunteer clinical research database registry allows us to maintain our high standards of data quality and patient safety and improves our ability to enroll qualified research subjects in a timely manner.”

ICON will use the Verified Clinical Trials volunteer registry in its Clinical Pharmacology units located in San Antonio, Texas and Omaha, Nebraska.

About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, RSVP or visit verifiedclinicaltrials.com.

Media Contacts
Verified Clinical Trials
Kerri Weingard, Chief Operating Officer, Verified Clinical Trials
Tel: +1 516 998-7499
KWeingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/2012/12/prweb10240744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... N.C. (PRWEB) , ... October 11, 2017 , ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, ... ( ASTER Labs ), Inc. has been selected for membership in ARCS ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Biology News(10 mins):